REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 2.00 (5.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 41.00
FIPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New University Agreement

26 May 2011 07:00

RNS Number : 3083H
Frontier IP Group plc
26 May 2011
 



 

AIM: FIPP

 

Frontier IP Group Plc

("Frontier IP" or "the Company")

 

IP Commercialisation Relationship with University of Plymouth

 

Frontier IP (AIM: FIPP), which specialises in the commercialisation of university intellectual property ("IP"), is pleased to announce that it has been selected as the University of Plymouth's ("the University") IP commercialisation strategic partner following a competitive tender process. The Company has entered into a 10-year IP commercialisation agreement with the University, with a mutual option to extend for a further 10 years.

 

Under the terms of the agreement, Frontier IP will assist the University in the commercialisation of its IP across all faculties. In return for its advisory services, Frontier IP will receive a share of the income from all new licences and a percentage of the equity in each new spin-out company. The University of Plymouth is Frontier IP's third university partner, in addition to the University of Dundee and Robert Gordon University, Aberdeen.

 

The University of Plymouth is ranked as one of the top 50 research universities in the UK and 80 per cent. of its research has been judged "of international repute" *.  In particular, the University has a world-class reputation for its research in marine sciences (operating Europe's largest marine institute), medical sciences, computer science and informatics and environmental sciences. It has a well established reputation for fostering innovation and has sought to build strong links between its research activities and industry. An early focus for Frontier IP will be the University's plans for a Centre for Translational Bio-Medicine.

 

Neil Crabb, Frontier IP's Executive Chairman, commented,

 

"We are delighted to have signed this agreement with the University of Plymouth. The University has a reputation for excellence in its research and we believe that there are exciting opportunities to aid the commercial development of some very interesting research projects."

 

Professor Wendy Purcell, Vice-Chancellor of the University of Plymouth said,

 

"We are delighted to be working with Frontier IP who bring us additional expertise in commercialising intellectual property and access to funding. This strategic relationship will help us to harness fully our ability to commercialise our knowledge base and it will have a major impact on our partnership-led approach to grow the knowledge economy in the region and create jobs."

 

 

*according to the latest Research Assessment Exercise (published in 2008 and conducted by the Higher Education Funding Council for England, the Scottish Funding Council, the Higher Education Funding Council for Wales and the Department for Employment and Learning, Northern Ireland)

 

 

 

For further information please contact:

 

Frontier IP Group Plc

Neil Crabb, Executive Chairman

 

T: 0131 220 9491

Arbuthnot Securities Limited

Tom Griffiths

Ed Groome

 

T: 020 7012 2000

Biddicks

Katie Tzouliadis

Sophie Lane

T: 020 3178 6378

 

About Frontier IP Group plc

www.frontierip.co.uk

 

Frontier IP specialises in the commercialisation of the intellectual property developed by universities and research institutions. It establishes partnerships with individual universities and research institutions to assist with their spin-out and licensing activities, and helps maximise the commercial value of technologies emerging from their research programmes. Frontier IP is traded on the AIM market.

 

About the University of Plymouth

www.plymouth.ac.uk

 

The University of Plymouth is ranked as one of the top modern universities in the UK, with a strong record of excellence, enterprise and innovation across its teaching and research activities.

 

With around 30,000 students in total, the University is also one of the largest in the UK. It is ranked in the top 50 research universities in the UK (Source: Research Fortnight league tables) and has four government-funded Centres for Excellence in Teaching & Learning, the maximum awarded to any single institution in the UK. The results of the Research Assessment Exercise 2008 showed the majority of areas submitted by the University included world-leading research, achieving the highest rating possible, scoring 4 stars. Overall, 80% of the research was judged as being of international repute.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRUVVNRARAVUAR
Date   Source Headline
7th May 202410:15 amRNSTVG to collaborate with The Pirbright Institute
2nd May 20247:00 amRNSFrontier IP announces stake in DiaGen
17th Apr 20241:59 pmRNSHolding(s) in Company
12th Apr 20247:00 amRNSAppointment of Chief Financial Officer
2nd Apr 202412:44 pmRNSHolding(s) in Company
14th Mar 20247:00 amRNSUnaudited Half Year Results
4th Mar 20241:40 pmRNSHolding(s) in Company
29th Feb 20243:12 pmRNSSale of shares in Exscientia
30th Jan 202411:45 amRNSHolding(s) in Company
22nd Jan 20247:00 amRNSOctopus invest in Alusid as part of equity funding
29th Dec 202312:00 pmRNSTotal Voting Rights
19th Dec 20234:46 pmRNSHolding(s) in Company
15th Dec 20236:12 pmRNSReplacement - Result of AGM and Directorate Change
15th Dec 20232:07 pmRNSResult of AGM and Directorate Change
13th Dec 20237:00 amRNSPortfolio news - The Vaccine Group
11th Dec 20237:00 amRNSHolding(s) in Company
30th Nov 20235:00 pmRNSTotal Voting Rights
30th Nov 20237:00 amRNSExercise of Options & Director/PDMR Shareholdings
28th Nov 20237:00 amRNSBoard Change
21st Nov 20237:00 amRNSPosting of Annual Report and Notice of AGM
9th Nov 20235:27 pmRNSHolding(s) in Company
3rd Nov 20237:05 amRNSGrant of options
1st Nov 20235:48 pmRNSExercise of Options & PDMR Shareholdings & TVR
31st Oct 20237:01 amRNSBoard changes
31st Oct 20237:00 amRNSFinal results for the year ended 30 June 2023
23rd Oct 20237:00 amRNSNew portfolio company Deakin Bio-Hybrid Materials
12th Oct 20232:05 pmRNSHolding(s) in Company
21st Sep 20237:00 amRNSExscientia announces collaboration with Merck
14th Sep 20235:21 pmRNSHolding(s) in Company
14th Sep 20237:00 amRNSExercise of Options & Total Voting Rights
11th Sep 20237:00 amRNSPortfolio news – Pulsiv appoints Chairman and CPO
8th Sep 20237:00 amRNSExercise of Options & Total Voting Rights
10th Aug 20238:45 amRNSPortfolio news – Fieldwork Robotics
24th Jul 20237:00 amRNSPortfolio news – CamGraPhIC loan facility
20th Jul 20235:18 pmRNSHolding(s) in Company
1st Jun 20237:00 amRNSSale of shares in Exscientia
26th May 20236:06 pmRNSHolding(s) in Company
9th May 20237:00 amRNSTopps Tiles launches first Alusid made tile range
21st Apr 20234:00 pmRNSDirectorate Change
20th Apr 20235:26 pmRNSHolding(s) in Company
27th Mar 20235:17 pmRNSHolding(s) in Company
17th Mar 20232:46 pmRNSGrant of options
15th Mar 20237:00 amRNSBoard changes
15th Mar 20237:00 amRNSUnaudited Half Year Results
30th Jan 20237:00 amRNSAlusid in collaboration with Imerys
9th Jan 20237:00 amRNSCelerum appoints David Gladding as CEO
9th Dec 20224:08 pmRNSResult of AGM
7th Dec 20221:25 pmEQSThe Vaccine Group completes two deadly disease vaccination projects
6th Dec 20227:00 amRNSFrontier IP to host Portfolio Demo Day
5th Dec 20227:00 amRNSThe Vaccine Group completes Lassa fever project

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.